Daroupakhsh Pharmaceutical Mfg (XTEH:DPAK1) EPS (Diluted) : IRR (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Daroupakhsh Pharmaceutical Mfg EPS (Diluted)?

Daroupakhsh Pharmaceutical Mfg's Earnings per Share (Diluted) for the six months ended in . 20 was IRR0.00.

Daroupakhsh Pharmaceutical Mfg's EPS (Basic) for the six months ended in . 20 was IRR0.00.

Daroupakhsh Pharmaceutical Mfg's EPS without NRI for the six months ended in . 20 was IRR0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Daroupakhsh Pharmaceutical Mfg EPS (Diluted) Historical Data

The historical data trend for Daroupakhsh Pharmaceutical Mfg's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daroupakhsh Pharmaceutical Mfg EPS (Diluted) Chart

Daroupakhsh Pharmaceutical Mfg Annual Data

Trend

EPS (Diluted)

Daroupakhsh Pharmaceutical Mfg Semi-Annual Data

EPS (Diluted)

Competitive Comparison of Daroupakhsh Pharmaceutical Mfg's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Daroupakhsh Pharmaceutical Mfg's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daroupakhsh Pharmaceutical Mfg's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daroupakhsh Pharmaceutical Mfg's PE Ratio distribution charts can be found below:

* The bar in red indicates where Daroupakhsh Pharmaceutical Mfg's PE Ratio falls into.

Daroupakhsh Pharmaceutical Mfg EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Daroupakhsh Pharmaceutical Mfg's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(	-	)	/	0
	=

Daroupakhsh Pharmaceutical Mfg's Diluted EPS for the quarter that ended in . 20 is calculated as

Diluted EPS (Q: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(	-	)	/	0
	=

Daroupakhsh Pharmaceutical Mfg (XTEH:DPAK1) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Daroupakhsh Pharmaceutical Mfg EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Daroupakhsh Pharmaceutical Mfg's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Daroupakhsh Pharmaceutical Mfg (XTEH:DPAK1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daroupakhsh Pharmaceutical Mfg (XTEH:DPAK1) » Definitions » EPS (Diluted)

Traded in Other Exchanges

N/A

Address

Darou Pakhsh Street, Km 18 Tehran-Karaj highway, Tehran, IRN, 1397116396

Website

http://www.dppharma.ir

Daroupakhsh Pharmaceutical Mfg is a pharmaceutical company based in Iran. It is engaged in developing and manufacturing a wide range of medical therapeutics including infertility, cardiology, diabetology, and neurology. It offers drugs in the form of tablet, injection, capsule, powder, ointment, gel, and syrup. Products offered by the company include Acetaminophen, Diazoxide, Galsulfase, Ketorolac, Isotretinoin, Mupirocin, Risperidone, Sulfasalazine, Tacrolimus, among others.

Daroupakhsh Pharmaceutical Mfg (XTEH:DPAK1) Headlines

No Headlines